(6R,9aR)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxohexahydro-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide

ID: ALA5291202

Chembl Id: CHEMBL5291202

Max Phase: Preclinical

Molecular Formula: C33H32N4O4

Molecular Weight: 548.64

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1[C@@H](Cc2ccc(O)cc2)N2C(=O)CCN(C(=O)NCc3ccccc3)[C@@H]2CN1Cc1cccc2ccccc12

Standard InChI:  InChI=1S/C33H32N4O4/c38-27-15-13-23(14-16-27)19-29-32(40)35(21-26-11-6-10-25-9-4-5-12-28(25)26)22-30-36(18-17-31(39)37(29)30)33(41)34-20-24-7-2-1-3-8-24/h1-16,29-30,38H,17-22H2,(H,34,41)/t29-,30+/m1/s1

Standard InChI Key:  HQWTUOLCGKIECB-IHLOFXLRSA-N

Alternative Forms

  1. Parent:

    ALA5291202

    ---

Associated Targets(Human)

TCF7 Tbio Catenin beta-1/Transcription factor 7 (9 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 548.64Molecular Weight (Monoisotopic): 548.2424AlogP: 4.27#Rotatable Bonds: 6
Polar Surface Area: 93.19Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.50CX Basic pKa: CX LogP: 4.12CX LogD: 4.12
Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.38Np Likeness Score: -0.43

References

1. Phull MS, Jadav SS, Gundla R, Mainkar PS..  (2021)  A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.,  212  [PMID:33445154] [10.1016/j.ejmech.2020.113149]

Source